Immunome (IMNM) announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell ...
The first proposal, which passed with 7,103,569 votes for and 3,340,296 against, involved the approval of the issuance of up to 19,762,226 shares of common stock. These shares are issuable upon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback